Your browser doesn't support javascript.
loading
Corrigendum to 'Demographic and clinical characteristics of type 2 diabetes mellitus patients initiating dipeptidyl peptidase-4 inhibitors - a retrospective study of UK general practice'.
Tebboth, Abigail; Lee, Sally; Scowcroft, Anna; Bingham-Gardiner, Paula; Spencer, William; Bolodeoku, John; Hassan, Syed Wasi.
Affiliation
  • Tebboth A; Boehringer Ingelheim Ltd, Berkshire, United Kingdom. Electronic address: abby.tebboth@boehringer-ingelheim.com.
  • Lee S; Boehringer Ingelheim Ltd, Berkshire, United Kingdom.
  • Scowcroft A; Boehringer Ingelheim Ltd, Berkshire, United Kingdom.
  • Bingham-Gardiner P; Boehringer Ingelheim Ltd, Berkshire, United Kingdom.
  • Spencer W; Boehringer Ingelheim Ltd, Berkshire, United Kingdom.
  • Bolodeoku J; Eli Lilly and Company, Basingstoke, United Kingdom.
  • Hassan SW; Eli Lilly and Company, Basingstoke, United Kingdom.
Clin Ther ; 39(6): 1266-1270, 2017 06.
Article in En | MEDLINE | ID: mdl-28522209
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies Language: En Journal: Clin Ther Year: 2017 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies Language: En Journal: Clin Ther Year: 2017 Document type: Article